Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial

This publication has 26 references indexed in Scilit:

• Adjuvant Adoptive Immunotherapy Against Hepatocellular Carcinoma
  Hepatology, 1998
• Hematogenous Spreading of Hepatocellular Carcinoma Cells: Possible Participation in Recurrence in the Liver
  Hepatology, 1997
• Cytotoxic Activity of CD4⁺ T Cells against Autologous Tumor Cells
  Japanese Journal of Cancer Research, 1995
• Distribution and therapeutic effect of intraarterially transferred tumor-infiltrating lymphocytes in hepatic malignancies. A preliminary report
  Cancer, 1991
• Induction of autologous tumor-specific cytotoxic T cells in patients with liver cancer. Characterizations and clinical utilization
  International Journal of Cancer, 1991
• Intrahepatic Recurrence After Resection of Hepatocellular Carcinoma Complicating Cirrhosis
  Annals of Surgery, 1991
• Effect of autolymphocyte therapy on survival and quality of life in patients with metastatic renal-cell carcinoma
  The Lancet, 1990
• Adoptive immunotherapy with lymphokine-activated killer cells plus recombinant interleukin 2 in patients with unresectable hepatocellular carcinoma
  Hepatology, 1989
• Expression of class I and class II major histocompatibility antigens on human hepatocellular carcinoma.
  Journal of Clinical Investigation, 1989
• A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
  New England Journal of Medicine, 1987